Pulmonx Statistics
Pulmonx (4NI) Stock Statistics & Valuation Metrics
Total Valuation
Pulmonx has a market cap or net worth of EUR 109.18M. The enterprise value is EUR 85.87M.
- Market Cap
- EUR 109.18M
- Enterprise Value
- EUR 85.87M
Share Statistics
Pulmonx has 43,550,667 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 43,550,667
- Owned by Insiders
- 12.15%
- Owned by Institutions
- 19.38%
Financial Efficiency
Pulmonx’s return on equity (ROE) is -1.00 and return on invested capital (ROIC) is -48.54%.
- Return on Equity (ROE)
- -1.00
- Return on Assets (ROA)
- -0.42
- Return on Invested Capital (ROIC)
- -48.54%
- Return on Capital Employed (ROCE)
- -0.49
- Revenue Per Employee
- 305.73K
- Profits Per Employee
- -182.44K
- Employee Count
- 296
- Asset Turnover
- 0.70
- Inventory Turnover
- 1.47
Valuation Ratios
The current PE Ratio of Pulmonx is -2.80. Pulmonx’s PEG ratio is -0.08.
- PE Ratio
- -2.80
- PS Ratio
- 1.37
- PB Ratio
- 3.53
- Price to FCF
- -4.76
- Price to Operating Cash Flow
- -4.73
- PEG Ratio
- -0.08
Income Statement
In the last 12 months, Pulmonx had revenue of 90.50M and earned -54.00M in profits. Earnings per share was -1.33.
- Revenue
- 90.50M
- Gross Profit
- 67.14M
- Operating Income
- -53.66M
- Pretax Income
- -53.38M
- Net Income
- -54.00M
- EBITDA
- -49.17M
- Earnings Per Share (EPS)
- -1.33
Cash Flow
In the last 12 months, operating cash flow was -25.58M and capital expenditures -31,000, giving a free cash flow of -25.61M billion.
- Operating Cash Flow
- -25.58M
- Free Cash Flow
- -25.61M
- Free Cash Flow per Share
- -0.59
Dividends & Yields
Pulmonx pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -21.26%
- Earnings Yield
- -35.14%
Stock Price Statistics
- Beta
- 1.51
- 52-Week Price Change
- 46.67%
- 50-Day Moving Average
- 1.78
- 200-Day Moving Average
- 1.42
- Relative Strength Index (RSI)
- 61.21
- Average Volume (3m)
- ―
Important Dates
Pulmonx upcoming earnings date is Feb 24, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 27, 2026
- Next Earnings Date
- Feb 24, 2027
- Ex-Dividend Date
- ―
Financial Position
Pulmonx as a current ratio of 5.07, with Debt / Equity ratio of 104.15%
- Current Ratio
- 5.07
- Quick Ratio
- 4.28
- Debt to Market Cap
- 0.43
- Net Debt to EBITDA
- 0.28
- Interest Coverage Ratio
- -17.01
Taxes
In the past 12 months, Pulmonx has paid 626.00K in taxes.
- Income Tax
- 626.00K
- Effective Tax Rate
- -0.01
Enterprise Valuation
Pulmonx EV to EBITDA ratio is -3.37, with an EV/FCF ratio of -4.85.
- EV to Sales
- 1.40
- EV to EBITDA
- -3.37
- EV to Free Cash Flow
- -4.85
- EV to Operating Cash Flow
- -4.85
Balance Sheet
Pulmonx has EUR 52.69M in cash and marketable securities with EUR 56.35M in debt, giving a net cash position of -EUR 3.66M billion.
- Cash & Marketable Securities
- EUR 52.69M
- Total Debt
- EUR 56.35M
- Net Cash
- -EUR 3.66M
- Net Cash Per Share
- -EUR 0.08
- Tangible Book Value Per Share
- EUR 0.74
Margins
Gross margin is 77.42%, with operating margin of -44.39%, and net profit margin of -47.93%.
- Gross Margin
- 77.42%
- Operating Margin
- -44.39%
- Pretax Margin
- -47.24%
- Net Profit Margin
- -47.93%
- EBITDA Margin
- -41.51%
- EBIT Margin
- -42.51%
Analyst Forecast
The average price target for Pulmonx is EUR 3.25, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- EUR 3.25
- Price Target Upside
- 34.12% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 4
- Revenue Growth Forecast
- -8.07%
- EPS Growth Forecast
- 32.11%
Scores
- Smart Score
- 4
- AI Score
- ―
